Literature DB >> 11741226

Effect of rise in simulated inspiratory flow rate and carrier particle size on powder emptying from dry powder inhalers.

V Chavan1, R Dalby.   

Abstract

The purpose of this study was to evaluate the effect of carrier particle size and simulated inspiratory flow increase rate on emptying from dry powder inhalers (DPIs). Several flow rate ramps were created using a computer-generated voltage signal linked to an electronic proportioning valve with a fast response time. Different linear ramps were programmed to reach 30, 60, 90, and 120 L/minute over 1, 2, or 3 seconds. At the lower flow rates, 100-ms and 500-ms ramps were also investigated. Three DPIs, Spinhaler, Rotahaler, and Turbuhaler, were used to test the effect of flow rate ramp on powder emptying. To test the effect of carrier particle size, anhydrous lactose was sieved into 3 particle sizes, and 20 mg of each was introduced into #2 and #3 hard gelatin capsules for Spinhaler and Rotahaler, respectively. Emptying tests were also carried out using the on/off solenoid valve described in the United States Pharmacopeia (USP) (resulting in no ramp generation). Powder emptying increased from 9% to 46% for Rotahaler and 69% to 86% for Spinhaler from the shallowest (3 seconds to reach peak flow) to the 100-ms ramp for the 53- to 75 microm lactose size range at 30 L/minute. Similar trends were observed for larger particle size fractions at the same flow rate. However, at higher airflow rates (60, 90, and 120 L/minute), there was no significant increase in percentage of emptying within the ramps for a particular particle size range. Trends observed were similar for placebo-filled Turbuhaler and commercially available Rotacaps used with Rotahaler, with the steepest ramp demonstrating more complete emptying. Percentage of powder emptying determined by the USP solenoid valve overestimated the emitted dose compared with the ramp method at 30 L/minute for all 3 devices. Results indicate that there is a significant difference in powder emptying at 30 L/minute from the shallowest to the steepest ramp within a particular size range. Within a particular particle size range, the USP method produced more complete emptying than even the steepest ramp, especially at the lower flow rates. Thus, when the USP device is used to estimate DPI emptying at lower flow rates, the results are likely to overestimate DPI performance significantly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11741226      PMCID: PMC2751024          DOI: 10.1208/ps020210

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  6 in total

1.  Inspiratory flow rates through a novel dry powder inhaler (Clickhaler) in pediatric patients with asthma.

Authors:  N P Nantel; M T Newhouse
Journal:  J Aerosol Med       Date:  1999

2.  Review of dry powder inhalers.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-06-09       Impact factor: 15.470

3.  Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers.

Authors:  P Lucas; K Anderson; J N Staniforth
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

4.  The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers--implications for in vitro testing.

Authors:  A R Clark; A M Hollingworth
Journal:  J Aerosol Med       Date:  1993

Review 5.  ABC of asthma. Asthma in children: treatment.

Authors:  J Rees; J Price
Journal:  BMJ       Date:  1995-06-10

Review 6.  Principles of nebulizer-delivered drug therapy for asthma.

Authors:  C E Johnson
Journal:  Am J Hosp Pharm       Date:  1989-09
  6 in total
  8 in total

1.  Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.

Authors:  Gary P Martin; Christopher Marriott; Xian-Ming Zeng
Journal:  Pharm Res       Date:  2006-12-20       Impact factor: 4.200

Review 2.  Aerosol therapy for obstructive lung diseases: device selection and practice management issues.

Authors:  Michael W Sims
Journal:  Chest       Date:  2011-09       Impact factor: 9.410

3.  Inhalation performance of physically mixed dry powders evaluated with a simple simulator for human inspiratory flow patterns.

Authors:  Daiki Hira; Tomoyuki Okuda; Daisuke Kito; Kazunori Ishizeki; Toyoko Okada; Hirokazu Okamoto
Journal:  Pharm Res       Date:  2010-07-14       Impact factor: 4.200

4.  Effects of Moisture-Induced Crystallization on the Aerosol Performance of Spray Dried Amorphous Ciprofloxacin Powder Formulations.

Authors:  Nivedita Shetty; Lingfei Zeng; Sharad Mangal; Haichen Nie; Matthew R Rowles; Rui Guo; Youngwoo Han; Joon Hyeong Park; Qi Tony Zhou
Journal:  Pharm Res       Date:  2018-01-02       Impact factor: 4.200

5.  Influence of fluoxetine on olanzapine pharmacokinetics.

Authors:  Denis Gossen; Jean-Marie de Suray; Francois Vandenhende; Claude Onkelinx; Diamon Gangji
Journal:  AAPS PharmSci       Date:  2002

6.  Developing ways to evaluate in the laboratory how inhalation devices will be used by patients and care-givers: the need for clinically appropriate testing.

Authors:  Jolyon P Mitchell; Jason A Suggett
Journal:  AAPS PharmSciTech       Date:  2014-06-04       Impact factor: 3.246

7.  Inspiratory flow patterns with dry powder inhalers of low and medium flow resistance in patients with pulmonary arterial hypertension.

Authors:  Mariana Faria-Urbina; Keith T Ung; Laurie Lawler; Lawrence S Zisman; Aaron B Waxman
Journal:  Pulm Circ       Date:  2021-05-13       Impact factor: 3.017

8.  Appropriate use of a dry powder inhaler based on inhalation flow pattern.

Authors:  Tetsuri Kondo; Makoto Hibino; Toshimori Tanigaki; Stanley M Cassan; Sakurako Tajiri; Kenichro Akazawa
Journal:  J Pharm Health Care Sci       Date:  2017-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.